The German life science and medtech private equity firm SHS Capital has made a EUR 10 million investment in Simulands, a Swiss manufacturer of simulation devices for medical training of cardiovascular interventions. The investment aims to
Tags :Stefan Kohler
CombiGene and Spark Therapeutics, a member of the Roche Group and a fully integrated, commercial gene therapy company dedicated to the fight against genetic diseases, have entered into an exclusive collaboration and licensing agreement for
Atlas Antibodies, a global developer of advanced reagents for biomedical research based in Sweden, has agreed to acquire Evitria Group from its shareholders. The transaction closed on August 5, 2021. Vischer advised the sellers on this
The team was led by Stefan Kohler (IP / Life Sciences - pictured) and Christoph Niederer (Tax).
From wearables sensors to collect physiological data to DNA’s sequences analysis with AI-based mechanism to online health counseling: numerous digital health solutions are currently being tested, implemented and improved, but Switzerland is still lacking
MCAM Symalit acquires recycling activities from Minger Kunststofftechnik: the advisor
Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high performance materials, had announced in February to have entered into an agreement for the acquisition of all the recycling activities of Minger Kunststofftechnik through